18-Hydroxy-1-methyl-13-oxapentacyclo[10.6.1.02,10.05,9.015,19]nonadeca-2(10),3,5(9),12(19),14-pentaene-6,11,16-trione

• 分子结构分类: 有机化合物 - 苯类化合物 - 菲及其衍生物
• 英文名称: 18-Hydroxy-1-methyl-13-oxapentacyclo[10.6.1.02,10.05,9.015,19]nonadeca-2(10),3,5(9),12(19),14-pentaene-6,11,16-trione
• 化学式: C₁₉H₁₄O₅
• 分子量: 322.3
• InChiKey: SWJBYJJNDIXFSA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  24
• 可旋转键数：
  0
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  84.6
• 氢给体数：
  1
• 氢受体数：
  5

文献信息

• Method for synthesizing furanosteroids
  申请人：Jacobi Peter A.

  公开号：US20090143346A1

  公开（公告）日：2009-06-04

  The present invention is a method for synthesizing furanosteroids. The method involves intramolecular Diels-Alder/retro-Diels-Alder reaction and tautomerization of a functionalized alkyne oxazole to produce a furo[2,3-b]phenol derivative which is elaborated by intermolecular and intramolecular condensations to generate ring-A of the furanosteroid. Furanosteroids and pharmaceutical compositions containing the same are also provided.

  本发明涉及一种合成呋喃甾体的方法。该方法涉及分子内Diels-Alder/retro-Diels-Alder反应和一个官能化炔基噁唑的异构化，以产生一种furo[2,3-b]苯酚衍生物，通过分子间和分子内缩合反应来生成呋喃甾体的A环。同时还提供了呋喃甾体和含有其的药物组合物。
• METHODS AND COMPOSITIONS FOR TREATING NEOINTIMAL HYPERPLASIA
  申请人：Marks Andrew R.

  公开号：US20090274739A1

  公开（公告）日：2009-11-05

  The present invention relates to compositions containing an mTOR inhibitor, such as rapamycin or a rapamycin derivative, in combination with a PI3 kinase inhibitor and/or a leptin inhibitor, intraluminal devices configured to release such compositions, and methods for the treatment and/or prevention of intimal hyperplasia, vascular stenosis and/or restenosis comprising delivery of such compositions or intraluminal devices to subjects in need thereof. The compositions, intraluminal devices, and methods of the invention are particularly well-suited for the treatment or prevention of vascular stenosis and restenosis in obese and diabetic subjects.
• US8067583B2
  申请人：——

  公开号：US8067583B2

  公开（公告）日：2011-11-29